JohnThomasCallaghanMD

Associate Professor, Medicine, Indiana University School of Medicine

Dr. Callaghan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1481 W 10th St
Indianapolis, IN 46202
Phone+1 317-988-2624

Fax+1 317-988-9264

PubMed

409 citations
Olanzapine. Pharmacokinetic and pharmacodynamic profile.
John T. Callaghan, Richard F. Bergstrom, Louis R. Ptak, Charles M. Beasley
Clinical Pharmacokinetics. 1999-09-01
155 citations
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
Michael S. Hershfield, J T Callaghan, Wichittra Tassaneeyakul, T Mushiroda, Caroline F. Thorn
Clinical Pharmacology and Therapeutics. 2013-02-01
153 citations
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
Kelly E. Caudle, Allan E. Rettie, Michelle Whirl-Carrillo, L H Smith, Scott Mintzer
Clinical Pharmacology and Therapeutics. 2014-11-01

Journal Articles

Pharmacogenetic Testing in the Veterans Health Administration (VHA): Policy Recommendations from the VHA Clinical Pharmacogenetics Subcommittee
Jason L Vassy, Steven A Schichman, John T Callaghan, Nature